Attenuation of age-related muscle wasting and weakness in rats after formoterol treatment: therapeutic implications for sarcopenia.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The journals of gerontology. Series A, Biological sciences and medical sciences

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/GERONA/62.8.813PMID 17702871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aging and sarcopenia.

  2007cited by this paper
• Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol.

  2007cited by this paper
• Cardiac implications for the use of β2‐adrenoceptor agonists for the management of muscle wasting

  2006cited by this paper
• Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.

  2006cited by this paper
• Systemic administration of β2‐adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses

  2006cited by this paper
• Chronic Treatment with the β2-Adrenoceptor Agonist Prodrug BRL-47672 Impairs Rat Skeletal Muscle Function by Inducing a Comprehensive Shift to a Faster Muscle Phenotype

  2006cited by this paper
• Beta2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle.

  2005cited by this paper
• Chronic β-agonist administration affects cardiac function of adult but not old rats, independent of β-adrenoceptor density

  2005cited by this paper
• Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density.

  2005cited by this paper
• β2-Agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle

  2005cited by this paper
• Low Skeletal Muscle Mass Is Associated With Poor Structural Parameters of Bone and Impaired Balance in Elderly Men—The MINOS Study

  2004cited by this paper
• Pilot trial of albuterol in Duchenne and Becker muscular dystrophy

  2004cited by this paper
• β2‐Agonist administration reverses muscle wasting and improves muscle function in aged rats

  2004cited by this paper
• Efficacy and Safety of Formoterol Delivered Via a New Multidose Dry Powder Inhaler (Certihaler™) in Adolescents and Adults with Persistent Asthma

  2004cited by this paper
• Invited review: Aging and sarcopenia.

  2003cited by this paper
• Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial

  2003cited by this paper
• Duality of G protein-coupled mechanisms for beta-adrenergic activation of NKCC activity in skeletal muscle.

  2002cited by this paper
• Manipulation of growth in pigs through treatment of the neonate with clenbuterol and somatotropin.

  2002cited by this paper
• Age Increases Cardiac Gαi2 Expression, Resulting in Enhanced Coupling to G Protein-coupled Receptors*

  2002cited by this paper
• Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.

  2002cited by this paper
• Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy

  2001cited by this paper
• Aging-Related Changes in Skeletal Muscle

  2000cited by this paper
• Sarcopenia: current concepts.

  2000cited by this paper
• Alterations in myocardial signal transduction due to aging and chronic dynamic exercise.

  1998cited by this paper
• Pilot trial of albuterol in facioscapulohumeral muscular dystrophy

  1998cited by this paper
• Cyclic AMP accumulation in rat soleus muscle: stimulation by beta2- but not beta3-adrenoceptors.

  1998cited by this paper
• Cyclic AMP accumulation in rat soleus muscle: stimulation by β2- but not β3-adrenoceptors

  1998cited by this paper
• Effect of aging on rat skeletal muscle beta-AR function in male Fischer 344 x brown Norway rats.

  1996cited by this paper
• Properties of single motor units in medial gastrocnemius muscles of adult and old rats.

  1996cited by this paper
• Anabolic effects of clenbuterol after long-term treatment and withdrawal in t the rat.

  1994cited by this paper
• Effects of energy allowance and cimaterol feeding during the heifer rearing period on growth, puberty and milk production

  1994cited by this paper
• The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit.

  1993cited by this paper
• Effects of exercise on myocardial adenylate cyclase and Gi alpha expression in senescence.

  1993cited by this paper
• β‐Adrenergic Receptor Distribution Among Muscle Fiber Types and Resistance Arterioles of Winte, Red, and Intermediate Skeletal Muscle

  1989cited by this paper
• Effect of the beta-adrenergic agonist cimaterol (CL 263,780) on the growth and carcass characteristics of finishing swine.

  1985cited by this paper
• Chronic effects of β2 agonists on body composition and protein synthesis in the rat

  1984cited by this paper

• Fibre Type–Specific Proteomics Reveals Shared and Distinct Skeletal Muscle Adaptations to Resistance Training and Beta2‐Adrenergic Agonist

  2026cites this paper
• Age-related changes in adrenergic regulation of contractility and redox status of glycolytic and oxidative skeletal muscles.

  2025cites this paper
• Activation of the β2-adrenoceptor by formoterol induces calcium-dependent exocytosis of synaptic vesicles at the neuromuscular junction in a sex-specific manner.

  2025cites this paper
• CD9, a novel potential biomarker of sarcopenia

  2025cites this paper
• A Pilot Study on the Effects of Medium-Chain Triglyceride-Enriched Oral Nutritional Supplementation on Nutritional Status, Physical Function, and Cognitive Function in Older Facility Residents

  2025cites this paper
• Possible Extracellular Signals to Ameliorate Sarcopenia in Response to Medium-Chain Triglycerides (8:0 and 10:0) in Frail Older Adults

  2024cites this paper
• β2-Adrenoceptors activation regulates muscle trophic-related genes following acute resistance exercise in mice

  2024cites this paper
• Counteracting Muscle Atrophy on Earth and in Space via Nanofluidics Delivery of Formoterol

  2020cites this paper
• Theaflavins decrease skeletal muscle wasting in disuse atrophy induced by hindlimb suspension in mice

  2020cites this paper
• cAMP‐dependent protein kinase inhibits FoxO activity and regulates skeletal muscle plasticity in mice

  2020cites this paper
• Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies

  2019cites this paper
• Insulin/IGF1 signalling mediates the effects of β2‐adrenergic agonist on muscle proteostasis and growth

  2019cites this paper
• The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice

  2018cites this paper
• Therapeutic potential of heat shock protein induction for muscular dystrophy and other muscle wasting conditions

  2018cites this paper
• Beta2‐adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men

  2018cites this paper
• Muscle Atrophy in Cancer.

  2018cites this paper
• Evaluation of the effect of cholesterol supplementation on experimental pulmonary arterial hypertension

  2018cites this paper
• Flavan 3‐ol delays the progression of disuse atrophy induced by hindlimb suspension in mice

  2017cites this paper
• Therapeutic Potential of Skeletal Muscle Plasticity and Slow Muscle Programming for Muscular Dystrophy and Related Muscle Conditions

  2017cites this paper
• Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size

  2016cites this paper
• Beta2-Agonist Doping Control and Optical Isomer Challenges

  2016cites this paper
• Déconditionnement et régénération du muscle strié squelettique : rôle du niveau d’activité contractile sur le développement d’infiltrations graisseuses

  2016cites this paper
• Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention.

  2016cites this paper
• Favorable effect of sympathetic nervous activity on rehabilitation outcomes in frail elderly.

  2015cites this paper
• Teràpia multimodal per al tractament de la caquèxia cancerosa

  2015cites this paper
• Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action.

  2015cites this paper
• Formoterol, a highly β2-selective agonist, induces gender-dimorphic whole body leucine metabolism in humans.

  2015cites this paper
• Aerobic Exercise Affects Myostatin Expression in Aged Rat Skeletal Muscles: A Possibility of Antiaging Effects of Aerobic Exercise Related With Pelvic Floor Muscle and Urethral Rhabdosphincter

  2014cites this paper
• Association of decreased sympathetic nervous activity with mortality of older adults in long‐term care

  2014cites this paper
• Motor unit changes seen with skeletal muscle sarcopenia in oldest old rats.

  2014cites this paper
• Creb coactivators direct anabolic responses and enhance performance of skeletal muscle

  2014cites this paper
• PAPEL DO ADRENOCEPTOR BETA 2 NA REGENERAÇÃO MUSCULAR ESQUELÉTICA

  2014cites this paper
• Muscle wasting in disease: molecular mechanisms and promising therapies

  2014cites this paper
• Sarcopenie : mécanismes et prévention : rôle de l'exercice et de l'hormone de croissance : implication du stress oxydant et de la glucose-6-phosphate déshydrogénase

  2014influential citation
• β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders.

  2013influential citation
• Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men

  2013cites this paper
• Metabolic reprogramming as a novel regulator of skeletal muscle development and regeneration

  2013cites this paper
• rat soleus muscles independently of Akt proteolysis and atrophy-related genes in denervated Clenbuterol suppresses proteasomal and lysosomal

  2012cites this paper
• Lack of β2‐AR improves exercise capacity and skeletal muscle oxidative phenotype in mice

  2012cites this paper
• Disruption of muscle renin-angiotensin system in AT1a-/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury.

  2012cites this paper
• The β2-adrenoceptor agonist formoterol improves structural and functional regenerative capacity of skeletal muscles from aged rat at the early stages of postinjury.

  2012cites this paper
• Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.

  2012cites this paper
• Etude des voies de signalisation impliquées dans la sarcopénie : rôle du stress oxydant et de l'inactivité physique

  2011cites this paper
• Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.

  2011cites this paper
• Role of β-Adrenergic Signalling in Skeletal Muscle Wasting: Implications for Sarcopenia

  2011cites this paper
• EFEITO DO AGONISTA B 2 -ADRENÉRGICO FORMOTEROL NA REGENERAÇÃO MUSCULAR DE RATOS IDOSOS

  2011cites this paper
• EFEITO DO AGONISTA B 2 -ADRENÉRGICO FORMOTEROL NA REGENERAÇÃO MUSCULAR DE RATOS IDOSOS

  2011cites this paper
• Eyelid Anatomy and Physiology with Reference to Blepharoptosis

  2011cites this paper
• Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β‐adrenoceptor stimulation in mice

  2010cites this paper
• The role of β-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders

  2009cites this paper
• Bedeutung der Proteinzufuhr bei der Entstehung und Behandlung der Sarkopenie

  2009cites this paper
• Activity-dependent and-independent control of circadian rhythms in mammalian skeletal muscle

  2009cites this paper
• The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting.

  2008influential citation
• ANABOLIC AGENTS FOR IMPROVING MUSCLE REGENERATION AND FUNCTION AFTER INJURY

  2008cites this paper
• Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness

  2008influential citation
• Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.

  2008cites this paper
• functional repair in rat skeletal muscle after myotoxic injury Intramuscular {beta}2-agonist administration enhances early regeneration and

  2008cites this paper
• Chronic (cid:1) 2 -adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca 2 (cid:2) -ATPase protein and activity

  2008cites this paper
• Update on emerging drugs for sarcopenia - age-related muscle wasting.

  2008cites this paper